Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 400

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells

Open access
Trabelsi, Mohamed-Sami, Daoudi, Mehdi, Prawitt, Janne, Ducastel, Sarah, Touche, Véronique, Sayin, Sama I., Perino, Alessia, Brighton, Cheryl A., Sebti, Yasmine, Kluza, Jérôme, Briand, Olivier, Dehondt, Hélène, Vallez, Emmanuelle, Dorchies, Emilie, Baud, Grégory, Spinelli, Valeria, Hennuyer, Nathalie, Caron, Sandrine, Bantubungi, Kadiombo, Caiazzo, Robert, Reimann, Frank, Marchetti, Philippe, Lefebvre, Philippe, Bäckhed, Fredrik, Gribble, Fiona M., Schoonjans, Kristina, Pattou, François, Tailleux, Anne, Staels, Bart, Lestavel, Sophie · 2015 · Nature Communications

Abstract

Bile acids are signalling molecules, which activate the transmembrane receptor TGR5 and the nuclear receptor FXR. BA sequestrants (BAS) complex bile acids in the intestinal lumen and decrease intestinal FXR activity. The BAS–BA complex also induces glucagon-like peptide-1 (GLP-1) production by L cells which potentiates β-cell glucose-induced insulin secretion. Whether FXR is expressed in L cells and controls GLP-1 production is unknown. Here, we show that FXR activation in L cells decreases proglucagon expression by interfering with the glucose-responsive factor Carbohydrate-Responsive Element Binding Protein (ChREBP) and GLP-1 secretion by inhibiting glycolysis. In vivo, FXR deficiency increases GLP-1 gene expression and secretion in response to glucose hence improving glucose metabolism. Moreover, treatment of ob/ob mice with the BAS colesevelam increases intestinal proglucagon gene expression and improves glycaemia in a FXR-dependent manner. These findings identify the FXR/GLP-1 pathway as a new mechanism of BA control of glucose metabolism and a pharmacological target for type 2 diabetes. Bile acids exert metabolic effects by modulating FXR receptor activity. Here, Trabelsi et al.show that FXR negatively regulates production of the incretin GLP-1 in enteroendocrine L-cells by reducing glycolysis and that inhibition of FXR improves glucose metabolism by increasing GLP-1 in obese mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms8629

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 43 references

Cited by

See all 400

Metadata

Authors
Trabelsi, M.-S., Daoudi, M., Prawitt, J., Ducastel, S., Touche, V., Sayin, S. I., Perino, A., Brighton, C. A., Sebti, Y., Kluza, J., Briand, O., Dehondt, H., Vallez, E., Dorchies, E., Baud, G., Spinelli, V., Hennuyer, N., Caron, S., Bantubungi, K., Caiazzo, R., Reimann, F., Marchetti, P., Lefebvre, P., Bäckhed, F., Gribble, F. M., Schoonjans, K., Pattou, F., Tailleux, A., Staels, B., & Lestavel, S.
Venue
Nature Communications
Published
2015-07-02
Volume
6
Issue
1
Pages
7629-7629
ISSN
2041-1723 (ISSN-L)
OpenAlex
W1821582942
Cited by
400
References
43
FWCI
23.54
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. https://app.cochat.ai/papers/10.1038/ncomms8629
The paper
Trabelsi, M.-S., Daoudi, M., Prawitt, J., Ducastel, S., Touche, V., Sayin, S. I., Perino, A., Brighton, C. A., Sebti, Y., Kluza, J., Briand, O., Dehondt, H., Vallez, E., Dorchies, E., Baud, G., Spinelli, V., Hennuyer, N., Caron, S., Bantubungi, K., . . . Lestavel, S. (2015). Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nature Communications. https://doi.org/10.1038/ncomms8629

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.